[144] Itron Inc SEC Filing

Rhea-AI Filing Summary

Form 144 notice for proposed sale of Itron, Inc. (ITRI) securities. The filer reports an intended sale of 565 common shares through Fidelity Brokerage Services with an aggregate market value of $70,798.51 and an approximate sale date of 08/25/2025 on NASDAQ. The shares were acquired on 08/22/2025 by restricted stock vesting from the issuer and were received as compensation. The filing also discloses three prior sales by John Marcolini during May–June 2025 totaling 11,233 shares for gross proceeds of $1,328,377.61. The submission includes the required representation about public disclosure and trading-plan statements. Some standard filer/issuer identification fields are blank in the provided text.

Positive

• Transparent disclosure of proposed sale details including shares, aggregate value, broker, and sale date
• Acquisition method clearly stated as restricted stock vesting and payment as compensation
• Prior sales reported for the past three months, providing continuity and transparency

Negative

• Significant prior insider selling in May–June 2025 totaling 11,233 shares for $1,328,377.61, which may raise stakeholder questions
• Missing filer/issuer identification fields in the provided excerpt reduce traceability and completeness of the filing

Insights

Securities Analyst

TL;DR: Routine insider sale filing showing a small planned sale after recent larger dispositions; appears procedural and compliance-oriented.

The Form 144 documents a proposed sale of 565 common shares valued at $70,798.51 to occur on 08/25/2025, acquired 08/22/2025 via restricted stock vesting as compensation. The filer also reported material dispositions earlier in May–June 2025 totaling 11,233 shares and $1,328,377.61 in gross proceeds. For investors, the filing is a compliance disclosure of insider sales rather than operational information about Itron. The filing lacks some identifying metadata in the excerpt, which limits traceability but does not change the nature of the reported transactions.

Corporate Governance Expert

TL;DR: Disclosure is consistent with Rule 144 requirements; prior substantial sales are notable but no nonpublic adverse information is claimed.

The notice states the signer represents no undisclosed material adverse information and records the acquisition method (restricted stock vesting) and payment nature (compensation). The sequential reporting of prior sales on 05/27/2025, 06/03/2025, and 06/04/2025 provides transparency about recent insider liquidity. Absence of complete issuer/filer identification in the excerpt reduces clarity for third-party verification, but the substantive sale details meet Rule 144 content expectations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	565	70798.51	45717933	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	Restricted Stock Vesting	Issuer			565	08/22/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John Marcolini 2111 N Molter Road Liberty Lake WA 99019	Common	05/27/2025	546	62760.02
John Marcolini 2111 N Molter Road Liberty Lake WA 99019	Common	06/03/2025	3783	441589.59
John Marcolini 2111 N Molter Road Liberty Lake WA 99019	Common	06/04/2025	6904	825028.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ITRI report?

The filing reports a proposed sale of 565 common shares valued at $70,798.51 to be sold on 08/25/2025 through Fidelity Brokerage Services.

How were the 565 shares acquired according to the filing?

The shares were acquired on 08/22/2025 via restricted stock vesting and the nature of payment is listed as compensation.

Did the filer sell other ITRI shares recently?

Yes. The filer John Marcolini reported sales of 546 shares on 05/27/2025, 3,783 shares on 06/03/2025, and 6,904 shares on 06/04/2025, totaling 11,233 shares for gross proceeds of $1,328,377.61.

Which broker will handle the proposed sale?

The sale is to be executed through Fidelity Brokerage Services LLC at the address shown in the filing.

Does the filing claim any undisclosed adverse information?

By signing, the person represents they do not know any material adverse information